Embla Medical hf Logo

Embla Medical hf

Global provider of non-invasive orthopedics, prosthetics, and mobility solutions.

EMBLA | CO

Overview

Corporate Details

ISIN(s):
IS0000000040
LEI:
213800K2AVTAFWJ4DP64
Country:
Iceland
Address:
5 GRJOTHALS, 110 REYKJAVIK
Sector:
Manufacturing
Industry:
Manufacture of medical and dental instruments and supplies

Description

Embla Medical hf, formerly Össur hf, is a leading global provider of non-invasive orthopedic products and innovative mobility solutions. The company's primary business segments include Prosthetics, Neuro Orthotics, and Bracing & Supports. Embla Medical operates as the parent organization for a portfolio of product brands, including Össur, College Park, and FIOR & GENTZ. In addition to developing and manufacturing products, the company provides patient services through a global network of Orthotic & Prosthetic (O&P) care facilities. The company's stated mission is to help people live a "Life Without Limitations" by enhancing mobility and well-being through its comprehensive offerings.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-06 17:00
Transaction in Own Shares
English 19.4 KB
2025-10-06 17:00
Transaction in Own Shares
English 127.0 KB
2025-09-29 17:00
Transaction in Own Shares
English 19.4 KB
2025-09-29 17:00
Transaction in Own Shares
English 141.1 KB
2025-09-22 17:00
Transaction in Own Shares
English 19.4 KB
2025-09-22 17:00
Transaction in Own Shares
English 160.3 KB
2025-09-15 17:00
Transaction in Own Shares
English 170.7 KB
2025-09-15 17:00
Transaction in Own Shares
English 19.4 KB
2025-09-09 17:00
Transaction in Own Shares
English 19.4 KB
2025-09-09 17:00
Transaction in Own Shares
English 118.0 KB
2025-09-03 20:30
Share Issue/Capital Change
English 10.3 KB
2025-09-03 20:30
Share Issue/Capital Change
English 143.4 KB
2025-09-03 20:30
Registration Form
English 430.2 KB
2025-09-03 20:30
Registration Form
Icelandic 434.9 KB
2025-09-01 17:00
Transaction in Own Shares
English 119.1 KB

Automate Your Workflow. Get a real-time feed of all Embla Medical hf filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Embla Medical hf via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Develops photodisinfection therapies to combat antimicrobial resistance and prevent infections.
Canada N/A
Onward Medical N.V. Logo
Develops spinal stimulation therapies to restore movement for people with spinal cord injury.
Netherlands ONWD
OSANG HEALTHCARE CO.,LTD. Logo
Develops and manufactures IVD medical devices and biosensors for diabetes management and health monitoring.
South Korea 036220
OssDsign AB Logo
Develops and markets nanosynthetic bone graft putty for spinal fusion surgery.
Sweden OSSD
OSTEONIC Co., Ltd. Logo
Manufactures metal & biodegradable bone fixation implants for CMF, trauma & sports medicine.
South Korea 226400
Otofarma S.p.A. Logo
Provides tailored hearing solutions and remote diagnostics through a partner pharmacy network.
Italy OTO
Manufactures medical beds and furniture for hospitals, nursing facilities, and home care.
Japan 7817
Paul Hartmann AG Logo
Provides medical and hygiene solutions for wound, incontinence, and infection management.
Germany PHH2
Paxman AB Logo
Specializing in scalp cooling systems to minimize hair loss for chemotherapy patients.
Sweden PAX
Provides multi-immune IVD systems and rapid test kits to the global medical diagnostics market.
South Korea 241820

Talk to a Data Expert

Have a question? We'll get back to you promptly.